Expert discusses advocacy for maintaining telemedicine reimbursement
“I think one of the hottest topics for advocacy right now relates to reimbursement for telemedicine,” says Amanda C. North, MD.
“I think one of the hottest topics for advocacy right now relates to reimbursement for telemedicine,” says Amanda C. North, MD.
“[The care plan] incorporates patient-specific data to reinforce dietary management, fluid intake, and medication adherence based on the patient’s 24-hour urine collection results,” says Jenny…
Brian Shuch, MD, and Neal Shore, MD, FACS, discuss the staging and treatment of kidney cancer, including when to biopsy and how often to do…
In this interview, Mary-Ellen Taplin, MD, discusses disparities in prostate cancer care and a unique initiative aiming to alleviate those disparities.
“Along those lines, we’ve taken away the traditional step therapy that has dictated overactive bladder care for quite some time,” says Ariana L. Smith, MD,…
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
“Prolaris precisely describes the difference in metastasis outcomes for men receiving monotherapy (RT) vs multimodal therapy (RT+ADT), and further tells me precisely what the risk…
“In our commercial all-comers cohort of patients undergoing Aquablation, efficacy was similar to and safety was improved compared to the WATER I and WATER II…
“225Ac-PSMA-Trillium is a novel approach, which could provide a new treatment to address this unmet need in mCRPC,” says Fred Saad, MD, FRCS.
“In general, risk is related to return: the higher the risk, the higher the potential return; the lower the risk, the lower the potential return,”…
“One of the main summaries/focuses of this discussion was, how do we create action to improve screening, and what that actually means,” says Samuel L.…